Latest News

Sienna Granted U.S. Patent for its hTERT IVD
01-Jul-2019

U.S. Patent No. 10,338,072 granted to Sienna by the United States Patent and Trademark Offi.. READ MORE

Investor Update June 2019
19-Jun-2019

Update on Sienna Cancer Diagnostics emailed to investors including our latest news & media cover.. READ MORE

Sienna Granted Chinese Patent for SIEN-NET™
22-May-2019

Sienna is pleased to announced the grant of a second patent in China for the liquid biopsy sampl.. READ MORE

Investor Information

Sienna is a public listed company headquartered in Melbourne, Australia. In August 2017, Sienna listed on the Australian Securities Exchange under the ticker symbol SDX. The company is governed by an experienced board and management team. Sienna has benefited from over $6.9M in R&D Tax Incentive refunds and government grant programs, significantly bolstering investor contributions and facilitating the progress and growth to date. READ MORE

 

Research

Sienna’s core activities have historically focused on the clinical translation of biomarkers using novel diagnostic technologies for applications in pathology laboratories. The development of inexpensive, high performing in vitro diagnostic tests is expected to lead to radical changes in the approach to care and assessment of cancer patients – a change welcomed by clinicians and governments.  READ MORE

 

About Sienna

Sienna is a medical technology company focussed on the development and commercialisation of novel IVD (in vitro diagnostic) tests. Sienna manufactures IVD products for pathology laboratories to use in their menu of testing services. READ MORE

Sienna has launched its first IVD product for the detection of hTERT, and is working on expansion of the product development and commercialisation pipeline. NETs technology will play a key role in the sample preparation step for future IVD products.


– CEO, Matthew Hoskin

Contact Sienna

Sienna Cancer Diagnostics

1 Dalmore Drive Scoresby VIC 3179 Australia

Telephone +61 3 8288 2141 Facsimile +61 3 8288 2059